DOX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Amdocs Ltd (DOX) is a good buy for a beginner investor with a long-term investment strategy and $50,000-$100,000 available. The company's solid financial performance, recent price momentum, and positive analyst sentiment outweigh short-term technical weaknesses and hedge fund selling trends.
The technical indicators are mixed to slightly bearish. The MACD is below zero and negatively contracting, RSI is neutral at 51.65, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). However, the stock closed above the key resistance level R1 (70.748), suggesting potential bullish momentum. The stock has an 80% chance of gaining 4.27% in the next week and 13.99% in the next month.
Strong financial performance in Q1 2026, with revenue up 4.13% YoY, net income up 4.17% YoY, and EPS up 9.02% YoY.
Analyst sentiment remains positive with Buy and Overweight ratings, and the T-Mobile contract renewal is a significant win.
The stock has shown strong recent price momentum, with a 5.13% gain in the regular market and a 1.64% post-market increase.
Hedge funds are selling, with a 1713.29% increase in selling activity over the last quarter.
Gross margin dropped by -3.58% YoY in Q1
No recent news or congress trading data to act as additional positive catalysts.
In Q1 2026, Amdocs reported revenue growth of 4.13% YoY to $1.16 billion, net income growth of 4.17% YoY to $154.53 million, and EPS growth of 9.02% YoY to $1.45. However, gross margin declined by -3.58% YoY to 35.79%. Overall, the financials indicate steady growth despite a slight margin contraction.
Analysts remain positive on Amdocs, with Barclays and Stifel maintaining Buy or Overweight ratings despite lowering price targets to $92 and $88, respectively. Analysts highlight the T-Mobile contract renewal and the company's resilient performance despite macroeconomic challenges.
